Study Characteristics and Risk of Bias of Clinical Trials Supporting FDA Approval of Cardiovascular Drugs, 2006-2020.

Shu, Meijun; Chen, Siliang; Li, Jiarui

Shu, Meijun; Chen, Siliang; Li, Jiarui.

Afiliação

Shu M; Eight-year M.D. Program, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730, Beijing, China.
Chen S; Eight-year M.D. Program, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730, Beijing, China.
Li J; Eight-year M.D. Program, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730, Beijing, China. lijiaruipumc@outlook.com.

J Gen Intern Med ; 37(11): 2888-2893, 2022 08.

Article em En | MEDLINE | ID: mdl-34704211

Assuntos

Fármacos Cardiovasculares; Viés; Aprovação de Drogas; Humanos; Estados Unidos/epidemiologia; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google